David Turkaly
Stock Analyst at JMP Securities
(2.36)
# 2,311
Out of 4,814 analysts
136
Total ratings
40.29%
Success rate
-3.07%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Reiterates: Market Outperform | $265 | $220.02 | +20.44% | 17 | Apr 10, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $129.55 | - | 15 | Apr 2, 2025 | |
| TELA TELA Bio | Maintains: Market Outperform | $12 → $7 | $0.94 | +643.89% | 6 | Mar 21, 2025 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $20.99 | +138.21% | 10 | Mar 21, 2025 | |
| AXGN Axogen | Reiterates: Market Outperform | $26 | $15.56 | +67.10% | 7 | Mar 5, 2025 | |
| IART Integra LifeSciences Holdings | Reiterates: Market Outperform | $35 | $15.80 | +121.52% | 14 | Feb 26, 2025 | |
| SIBN SI-BONE | Reiterates: Market Outperform | $32 | $13.92 | +129.97% | 7 | Feb 25, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $72.35 | - | 2 | Feb 24, 2025 | |
| SYK Stryker | Maintains: Market Perform | n/a | $346.60 | - | 2 | Feb 18, 2025 | |
| HAE Haemonetics | Maintains: Market Outperform | $125 → $100 | $58.23 | +71.75% | 11 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $7.87 | +103.43% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $101.32 | +10.54% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Outperform | $62 | $31.89 | +94.42% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.99 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.77 | -20.42% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $23 → $20 | $13.09 | +52.79% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $13.05 | - | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $160 → $140 | $97.88 | +43.03% | 13 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $3.23 | +23.84% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.51 | -47.40% | 1 | Oct 6, 2017 |
STERIS
Apr 10, 2025
Reiterates: Market Outperform
Price Target: $265
Current: $220.02
Upside: +20.44%
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $129.55
Upside: -
TELA Bio
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $0.94
Upside: +643.89%
OrthoPediatrics
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $20.99
Upside: +138.21%
Axogen
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $15.56
Upside: +67.10%
Integra LifeSciences Holdings
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $35
Current: $15.80
Upside: +121.52%
SI-BONE
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $13.92
Upside: +129.97%
Globus Medical
Feb 24, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $72.35
Upside: -
Stryker
Feb 18, 2025
Maintains: Market Perform
Price Target: n/a
Current: $346.60
Upside: -
Haemonetics
Feb 7, 2025
Maintains: Market Outperform
Price Target: $125 → $100
Current: $58.23
Upside: +71.75%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $7.87
Upside: +103.43%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $101.32
Upside: +10.54%
Oct 3, 2024
Initiates: Market Outperform
Price Target: $62
Current: $31.89
Upside: +94.42%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $0.99
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.77
Upside: -20.42%
May 9, 2024
Maintains: Market Outperform
Price Target: $23 → $20
Current: $13.09
Upside: +52.79%
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $13.05
Upside: -
Nov 13, 2023
Maintains: Market Outperform
Price Target: $160 → $140
Current: $97.88
Upside: +43.03%
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $3.23
Upside: +23.84%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.51
Upside: -47.40%